Elanco Animal Health wins U.S. approval to buy Bayer unit

Elanco to shed cattle pour-on brand, others for approval

Reading Time: < 1 minute Washington | Reuters — Elanco Animal Health has won U.S. antitrust approval to buy Bayer’s animal health business on condition that it sell assets to treat three ailments, two in dogs and one in cattle, the Federal Trade Commission said on Wednesday. The deal was valued at $7.6 billion when it was announced in August […] Read more

Elanco forgoes Canadian poultry insecticide rights for Bayer deal

Reading Time: < 1 minute Reuters — Elanco Animal Health has decided against acquiring Bayer’s Canadian distribution rights to several poultry insecticides, Canada’s Competition Bureau said on Tuesday, as it looks to complete a $7.6-billion deal. The U.S.-based company will also divest its canine ear infection treatment product Osurnia and Bayer’s feline dewormer Profender to address competition concerns about its […] Read more

Elanco gets EU’s conditional antitrust OK for Bayer deal

Approval calls for sale of Vecoxan brand, among others

Reading Time: < 1 minute Reuters/Staff — Elanco Animal Health secured antitrust clearance on Monday from the European Union to buy Bayer’s veterinary drugs unit, after pledging to sell some products to address competition concerns about the US$7.6 billion deal. The European Commission said the companies will sell either Elanco or Bayer’s products or those in the pipeline, including licenses, […] Read more

Elanco to become No. 2 in animal health with Bayer deal

Reading Time: 3 minutes Reuters — Elanco Animal Health agreed to buy Bayer’s veterinary drugs unit on Tuesday in a cash and stock deal valued at US$7.6 billion (C$10 billion), creating the second largest maker of medicines for livestock and pets and expanding Elanco’s reach online. The deal is the latest in the fast-growing animal health market, which has […] Read more

Bayer, Elanco said aiming to reach animal health deal next week

Reading Time: < 1 minute Reuters — Germany’s Bayer and U.S. drug firm Elanco Animal Health aim to reach an agreement to combine their animal health businesses as soon as next week, Bloomberg reported Wednesday, citing people with knowledge of the matter. Elanco plans to pay for at least a part of the deal with its stock and any deal […] Read more


Elanco buys swine PWD vaccine maker

Reading Time: 2 minutes Veterinary drugmaker Elanco Animal Health is expanding its space in the swine sector with a deal to buy the Quebec startup behind Coliprotec vaccines. Indianapolis-based Elanco announced Thursday it has paid $78.5 million to buy Prevtec Microbia, which is headquartered in Montreal with facilities in St-Hyacinthe. The Coliprotec line is meant to help protect pigs […] Read more

Animal health firm Elanco surges on trading debut

Reading Time: 2 minutes Reuters — Eli Lilly unit Elanco Animal Health’s shares jumped as much as 41 per cent on their stock market debut on Thursday, adding to investor enthusiasm for the fast-growing animal healthcare market. Elanco’s shares opened at $32.25 on the New York Stock Exchange, higher than their IPO price of $24 per share, giving the […] Read more



Mastitis preventive gets joint Canada/U.S. approval

Reading Time: 2 minutes A new drug to help limit mastitis in dairy cows — and keep a lid on the use of antimicrobials to treat it — has picked up joint approval from Health Canada and the U.S. Food and Drug Administration. The two agencies on Thursday announced “simultaneous” approvals for Elanco Animal Health’s injectable drug pegbovigrastim, to […] Read more